HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Danilo Toni Selected Research

4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)

12/2015IV thrombolysis in very severe and severe ischemic stroke: Results from the SITS-ISTR Registry.
11/2014Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.
7/2013Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
6/2012Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score.
1/2012Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study.
9/2010Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR.
9/2010Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: results from the Safe Implementation of Treatments in Stroke International Stroke Thrombolysis Register (SITS-ISTR).
7/2009Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR).
12/2008Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST).
10/2008Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Danilo Toni Research Topics

Disease

38Stroke (Strokes)
12/2015 - 01/2003
5Cerebral Hemorrhage
12/2015 - 12/2008
4Heart Failure
07/2015 - 09/2007
4Atrial Fibrillation
05/2015 - 09/2007
4Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2015 - 09/2008
3Hemorrhage
12/2015 - 06/2012
3Hypertension (High Blood Pressure)
06/2012 - 07/2009
3Body Weight (Weight, Body)
06/2012 - 09/2008
2Carotid Stenosis (Carotid Artery Stenosis)
06/2012 - 01/2012
2Transient Ischemic Attack
01/2012 - 08/2004
2Infarction
12/2008 - 09/2008
1Neoplasms (Cancer)
07/2015
1Renal Insufficiency (Renal Failure)
07/2015
1Nervous System Diseases (Neurological Disorders)
07/2015
1Infection
05/2015
1Purpura
01/2015
1Venous Thromboembolism
04/2013
1Diabetes Mellitus
01/2012
1Hyperlipidemias (Hyperlipidemia)
01/2012
1Brain Ischemia (Cerebral Ischemia)
03/2006
1Atherosclerotic Plaque (Atheroma)
03/2006

Drug/Important Bio-Agent (IBA)

16Tissue Plasminogen Activator (Alteplase)FDA Link
12/2015 - 01/2007
114- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA
12/2015 - 01/2007
5Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2014 - 09/2008
3Dipyridamole (Persantine)FDA LinkGeneric
10/2014 - 09/2008
3clopidogrel (Plavix)FDA Link
06/2012 - 09/2008
3Blood Glucose (Blood Sugar)IBA
01/2012 - 12/2008
3sirioIBA
01/2012 - 01/2009
3telmisartan (Micardis)FDA Link
11/2009 - 09/2008
2AnticoagulantsIBA
08/2015 - 10/2014
2Metalloproteases (Metalloproteinases)IBA
01/2015 - 10/2013
2Matrix MetalloproteinasesIBA
01/2015 - 10/2013
2Antihypertensive Agents (Antihypertensives)IBA
07/2011 - 07/2009
2AngiotensinsIBA
11/2009 - 09/2008
1AntibodiesIBA
05/2015
12,6-dinitrotoluene (DNT)IBA
05/2015
1Immunoglobulin A (IgA)IBA
05/2015
1Immunoglobulin G (IgG)IBA
05/2015
1Tissue Inhibitor of Metalloproteinases (TIMP)IBA
01/2015
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
10/2013
1rivaroxabanIBA
04/2013
1Factor Xa (Coagulation Factor Xa)IBA
04/2013
1Glucose (Dextrose)FDA LinkGeneric
06/2012
1SodiumIBA
04/2012
1CholesterolIBA
01/2012
1Angiotensin Receptors (Angiotensin II Receptor)IBA
10/2008
1Neuroprotective AgentsIBA
10/2008
1Hemoglobins (Hemoglobin)IBA
09/2007
1Brain Natriuretic Peptide (Natrecor)FDA Link
09/2007
1GalaninIBA
03/2006
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2006
1glucuronyl glucosamine glycan sulfate (Vessel)IBA
08/2004

Therapy/Procedure

3Thrombolytic Therapy
01/2012 - 01/2003
2Carotid Endarterectomy
06/2012 - 01/2012
1Palliative Care (Palliative Medicine)
07/2015
1Aftercare (After-Treatment)
11/2014
1Compression Stockings
10/2014
1Endarterectomy (Thromboendarterectomy)
01/2012
1Activities of Daily Living (ADL)
01/2012
1Self-Help Devices (Assistive Technology)
02/2009